Studies have identified CD44+CD24− in breast cancer [44]; CD44+CD24+EpCAM+ in pancreatic or ovarian cancer [45,46]; and a high expression of neuron stem markers, such as CD133, CD44, and Nestin, and transcript factors, such as SOX2 and OCT4, in GBM. This evidence concerns the gene NES and breast carcinoma.